Women's cognitive and affective health and neuropsychiatry

Mount Sinai Journal of Medicine

Volumn 73, Issue 7, 2006, Pages 967-975

  Aloysi, Amy ^a   Van Dyk, Kathleen ^b   Sano, Mary ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Affect; Cognition; Estrogen; Women's health

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINE ACETYLTRANSFERASE; CITALOPRAM; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DIENOGEST PLUS ESTRADIOL VALERATE; DOPAMINE; ESCITALOPRAM; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FOLLITROPIN; MIRTAZAPINE; NEUROTRANSMITTER; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; PROGESTERONE; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SOMATOMEDIN C; VENLAFAXINE;

AGING; ANXIETY DISORDER; BIPOLAR DISORDER; CELL PROTECTION; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DRUG EFFICACY; ENZYME INDUCTION; FEMALE; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPOTHESIS; MENOPAUSE; MENTAL HEALTH; MONOTHERAPY; MOOD DISORDER; NEUROPROTECTION; NEUROPSYCHIATRY; OXIDATIVE STRESS; PREMENSTRUAL SYNDROME; REVIEW; RISK REDUCTION; SCHIZOPHRENIA; SEX DIFFERENCE; TIME; TREATMENT OUTCOME; WOMEN'S HEALTH;

BIPOLAR DISORDER; COGNITION; COGNITION DISORDERS; ESTROGENS; FEMALE; HUMANS; MENOPAUSE; MOOD DISORDERS; PREVALENCE; SCHIZOPHRENIA; WOMEN'S HEALTH;

EID: 33845967823     PISSN: 00272507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Rasgon N, Shelton S, Halbreich U. Perimenopausal mental disorders: epidemiology and phenomenology. CNS Spectr 2005; 10(6):471-478.
2. McEwen BS. Genome and hormones: gender difference in physiology. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 2001; 91:2785-2801; http://jap.physiology-org/ cgi/content/full/91/6/2785
3. Matsuda Y, Hirano H, Watanabe Y. Effects of estrogen on acetylcholine release in frontal cortex of female rats: involvement of serotonergic neuronal systems. Brain Res 2000; 937(1-2):58-65.
4. Cavus I, Duman RS. Influence of estradiol, stress, and 5-HT2A agonist treatment on brain-derived neurotrophic factor expression in female rats. Biol Psychiatry 2003; 54(1):59-69.
5. Amin Z, Canli T, Epperson CN. Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev 1005; 4(1):43-58.
6. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions, implications for affective regulation. Biol Psychiatry 1998: 44(9):839-850.
7. Rybaczyk LA, Bashaw MJ, Pathak DR, et al. An overlooked connection: serotonergic mediation of estrogen-related physiology and pathology. BMC Womens Health 2005:5:12.
8. Raap DK, DonCarlos L, Garcia F, et al. Estrogen desensitizes 5HT(1A) receptors and reduces levels of G(z), G(i1) and G(i3) in the hypothalamus. Neuropharmacology 2000; 39(10):1823-1832.
9. Low LF, Anstey KJ, Jorm AF, et al. Reproductive period and cognitive function in a representative sample of naturally postmenopausal women aged 60-64 years. Climacteric 2005; 8(4):380-389.
10. LeBlanc ES, Janowsky J, Chan BK, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA 2001; 285(11):1489-1499.
11. Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988; 13(4):345-357.
12. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992; 17:485-495.
13. Vanhulle G, Demol R. A double-blind study into the influence of estriol on a number of psychological tests in postmenopausal women. In: Van Keep PA, Greenblatt RB, Albeaux Fernet M, editors. Consensus on menopausal research. Baltimore (MD): University Park Press, 1976. pp. 94-99.
14. Hackman BW, Galbraith D. Replacement therapy and piperazine oestrone sulphate ("Harmogen") and its effect on memory. Curr Med Res Opin 1976; 4(4):303-306.
15. Fedor-Freybergh P. The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand Suppl 1977; 64:1-91.
16. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991; 78:991-995.
17. Polo-Kantola P, Portin R, Polo O, et al. The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 1998; 91:459-466.
18. Shaywitz SE, Shaywitz BA, Pugh KR, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999; 281:1197-1202.
19. Shaywitz SE, Naftolin F, Zelterman D, et al. Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause 2003; 10(5):420-426.
20. Linzmayer L, Semlitsch HV, Saletu B, et al. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneimittelforschung 2001; 51(3):238-245.
21. Saletu-Zyhlarz G, Anderer P, Gruber G, et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 2003; 12(3):239-254.
22. Yaffe K, Krueger K, Cummings SR, et al. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry 2005; 162(4):683-690.
23. Shumaker SA, Reboussin BA, Espeland MA, et al. The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 1998; 19(6):604-621.
24. Shumaker SA, Legault C, Rapp SR, et al; WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 28; 289(20):2651-2662.
25. Wang PN, Liao SQ, Liu RS, et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 2000; 54(11):2061-2066.
26. Mulnard RA, Cotman CW, Kawas C, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease. JAMA 2000; 283:1007-1015.
27. Henderson VW, Paganini-Hill A, Miller BL, et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 2000; 54:295-301.
28. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al; WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003; 289(20):2673-2684.
29. Kessler RC, McGonagle KA, Swartz M, et al. Sex and depression in the National Comorbidity Survey I: lifetime prevalence, chronicity and recurrence. J Affect Disord 1993; 29(2-3):85-96.
30. Rasgon N, Shelton S, Halbreich U. Perimenopausal mental disorders: epidemiology and phenomenology. CNS Spectr 2005, 10:6: 471-478.
31. Harlow BL, Wise LA, Otto MW, et al. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with the menopausal transition: The Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2003; 60:29-36.
32. Freeman EW, Samual MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004; 61:62-70.
33. Schmidt PJ, Haq N, Rubinow DR. A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry 2004; 161(12):2238-2244.
34. Kaufert PA, Gilbert P, Tate R. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas 1992; 14(2):143-155.
35. Avis NE, Brambilla D. McKinlay SM. Vass K. A longitudinal analysis of the association between menopause and depression: results from the Massachusetts Women's Health Study. Ann Epidemiol 1994; 4:214-220.
36. Schmidt PJ. Mood, depression, and reproductive hormones in the menopausal transition. Am J Med 2005; 118(12B):54S-58S.
37. Richards M, Rubinow DR, Daly RC, Schmidt PJ. Premenstrual syndrome and perimenopausal depression. Am J Psychiatry 2006; 163(1):133-137.
38. Joffe H. Hall JE, Soares CN, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002; 9:392-398.
39. Schmidt PJ, Murphy JH, Haq N, et al. Basal plasma hormone levels in depressed premenopausal women. Psychoneuroendocrinology 2002; 27:907-920.
40. Schmidt PJ. Depression, the perimenopause, and estrogen therapy. Ann N Y Acad Sci 2005; 1052:27-40
41. Cohen LS, Soares CN, Joffe H. Diagnosis and management of mood disorders during the menopausal transition. Am J Med 2005; 118, 12B:935-975.
42. Soares, CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001; 58(6):529-534.
43. Schmidt PJ, Nieman L. Danaceau MA, et al. Estrogen replacement in menopausal transition-related depression: a preliminary report. Am J. Obstet Gynecol 2000; 183:414-420.
44. Morgan ML, Cook IA, Rapkin AJ, Leuchter AF. Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study. J Clin Psychiatry 2005; 66(6):774-780.
45. Goldstein KM, Harpole LH, Stechuchak KM, et al. Hormone therapy does not affect depression severity in older women. Am J Geriatr Psychiatry 2005; 13(7):616-623.
46. Heinrich AB, Wolf OT. Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: a questionnaire study. Neuropsychobiology 2005; 52(1):17-23.
47. Almeida OP, Lautenschlager NT, Vasikaran S, et al. A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol Aging 2006; 27(1):141-149.
48. Ladd CO, Newport DJ, Ragan KA, et al. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Depress Anxiety 2005; 22(2):94-97.
49. Cohen LS, Soares CN, Joffe H. Diagnosis and management of mood disorders during the menopausal transition. Am J Med 2005;118(12B):935-975.
50. Parry BL, Meliska CJ, Martinez LF, et al. Menopause: neuroendocrine changes and hormone replacement therapy. J Am Med Womens Assoc 2004; 59(2):135-145.
51. Uebelhack R, Blohmer JU, Graubaum HJ, et al. Black cohosh and St. John's wort for climacteric complaints: a randomized trial. Obstet Gynecol 2006; 107(2 Pt 1):247-255.
52. Freeman, EW, Sammel MD, Lin H, et al. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 2005; 12(3):258-266.
53. Almeida OP. Lautenschlager N, Vasikaram S, et al. Association Between Physiological Serum Concentration of Estrogen and the Mental Health of Community-Dwelling Postmenopausal Women Age 70 Years and Over. Am J Geriatr Psychiatry 2005; 13(2):142-149.
54. Bebbington P, Dunn G, Jenkins R, et al. The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity. Int Rev Psychiatry 2003; 15(1-2):74-83.
55. Nelson DB, Sammel MD, Freeman EW, et al. Predicting participation in prospective studies of ovarian aging. Menopause 2004; 11(5):543-548.
56. Riecher-Rossler A, Hafner H, Stumbaum M, et al. Can estradiol modulate schizophrenic symptomatology? Schizprh Bull 1994; 20(1):203-214.
57. Riecher-Rossler A, Hafner J, Dutsch-Strobel A, et al Further evidence for a specific role of estradiol in schizophrenia? Biol Psychiatry 1994; 36(7):492-494.
58. Hallonquist JD, Seeman MV, Lang M, Rector NA. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 1993; 33(3):207-209.